RAN BioLinks logo

RAN BioLinks

End-to-end research operations for clinical trials, biobanking, and biomedical studies—from participant engagement to omics analysis.

Visit website

Overview

RAN BioLinks is a technology-enabled services company that supports biomedical and clinical researchers by taking over operational tasks, providing research infrastructure, and connecting scientists with expert networks and resources. The company has worked with researchers globally for over 20 years and serves scientists at all career stages — including students, post-doctoral researchers, and principal investigators — who face challenges related to funding, logistics, data management, and regulatory compliance. Its stated mission is to make scientific research more accessible, efficient, and relevant by building capacity around modern research methods and reducing the operational burden on scientists.

RAN BioLinks offers an accelerator program designed to serve as a foundation for a community where researchers can connect, collaborate, and share their work. The company combines project management tools, business intelligence capabilities, and bioinformatics expertise to help researchers move from idea generation through to data analysis and commercialization.

Clinical Research Study Implementation

  • Provides evidence-based protocols designed to meet requirements for successful study implementation.
  • Supports researchers across multiple areas including education, behavior change communication, participant recruiting, retention, and research governance.
  • Helps satisfy regulatory compliance and data integrity requirements, with the aim of shortening recruitment cycles and reducing protocol deviations and outliers.

Biobanking and Biological Sample Workflows

  • Offers end-to-end biospecimen collection and management workflows, covering sample tracking, quality control, and data integration.
  • Provides real-time sample tracking features that record sample location, status, and history to ensure integrity and traceability.
  • Includes continuous data quality monitoring to identify and address issues promptly.
  • Delivers interactive dashboards tailored to biobanking projects, enabling monitoring of key metrics and inventory management.
  • Supports integration of data from multiple sources, including clinical and laboratory datasets, to provide a unified view of research.

Clinical Trials Logistics and Capabilities

  • Provides end-to-end pipelines covering participant engagement through to multiomic analysis.
  • Supplies standardized participant collection materials to minimize variability and support consistent data acquisition.
  • Offers omics analysis services spanning genomics, proteomics, and metabolomics using bioinformatics tools.
  • Maintains a data governance and security framework designed to ensure data integrity, confidentiality, and compliance throughout the research lifecycle.
  • Integrates participant collection, omics analysis, and data governance functions within a single platform to streamline workflows and support collaboration.

Platform and Operational Support

  • Provides automated systems intended to support reproducible research with reliable outputs.
  • Offers tools for project management and business analytics tailored to scientific research contexts.
  • Assists researchers in reducing operational risk prior to funding applications by efficiently addressing technical and logistical gaps.
  • Connects scientists with a network of domain experts to support research improvement and collaboration.

Notable Experience and Leadership

  • Supported the ConCorD19 study, in which over one thousand households were enrolled and followed up with home visits during pandemic lockdowns; the study was implemented within weeks of design and data was locked down within weeks of study end, according to a testimonial from Professor Tobias Kollmann, Professor of System Vaccinology.
  • Has managed day-to-day trial logistics including procurement of biospecimen collection kits and transportation supplies.
  • The company was co-founded by Ahmed Chakroun, Rad Aniba (PhD), and Rym Ben Othman (PhD).

RAN BioLinks positions itself as a research operations partner rather than a purely software-focused vendor, combining technology platforms with hands-on service delivery to address the full range of challenges researchers face from study design through data analysis and governance.